Updates are available Correction dated 2024-10-25

Article History

Received: 28 February 2024

Accepted: 9 July 2024

First Online: 16 July 2024

Change Date: 24 October 2024

Change Type: Update

Change Details: The given and family names for author Carmen San Román were mistakenly captured and have been corrected.

Change Date: 25 October 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s41927-024-00432-4

Declarations

:

: This study did not involve any collection of drug-related data and does not meet any of the criteria required to be considered as an observational clinical trial as defined in Article 2.1.i) in Spain’s Royal Decree 1090/2015 of December 4th as provided by the Ministerio de la Presidencia, Relaciones Con Las Cortes Y Memoria Democrática, which regulates observational studies with medicines for human use [] or as defined by the Spanish Agency for Medicines and Health Products []. Therefore, consistent with the Royal Decree and the Spanish Agency for Medicines and Health Products, evaluation and approval by an ethics committee, or IRB approval, was not required for this study [, ]. Prior to beginning the questionnaire, all participants were informed of the study structure, scientific committee, and the confidentiality and data protection measures that were in place. Written informed consent was obtained by all participants by checking a box indicating that they read and accepted the survey and agreed to participate in the study with all the conditions described.

: Not applicable.

: IC, LC, MJC, JB, MG, TS, AM declare that have received fees from GSK for her advice as member of the Scientific Committee of the Delphi Project. CA and CS are full-time GlaxoSmithKline employees and declare stock ownership. IC and MC work for an independent research entity that received funding from GlaxoSmithKline to coordinate and conduct the project.